KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Change in Accured Expenses (2020 - 2025)

Oscar Health (OSCR) has disclosed Change in Accured Expenses for 6 consecutive years, with $93.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 170.66% year-over-year to $93.9 million, compared with a TTM value of $205.5 million through Dec 2025, up 34.51%, and an annual FY2025 reading of $205.5 million, up 34.51% over the prior year.
  • Change in Accured Expenses was $93.9 million for Q4 2025 at Oscar Health, up from -$30.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $199.6 million in Q1 2025 and bottomed at -$58.0 million in Q2 2025.
  • Average Change in Accured Expenses over 5 years is $24.3 million, with a median of $18.8 million recorded in 2021.
  • The sharpest move saw Change in Accured Expenses tumbled 1182.15% in 2023, then skyrocketed 3887.82% in 2024.
  • Year by year, Change in Accured Expenses stood at $72.8 million in 2021, then plummeted by 39.63% to $44.0 million in 2022, then tumbled by 72.29% to $12.2 million in 2023, then skyrocketed by 184.66% to $34.7 million in 2024, then surged by 170.66% to $93.9 million in 2025.
  • Business Quant data shows Change in Accured Expenses for OSCR at $93.9 million in Q4 2025, -$30.0 million in Q3 2025, and -$58.0 million in Q2 2025.